Céline BALDEYRON

Dr. Céline BALDEYRON

Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, Île-de-France, France

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
JEJeroen Essers
Jeroen Essers
ATArjan F. Theil
Arjan F. Theil
CBCéline BALDEYRON
Céline BALDEYRON
WCWiggert A. van Cappellen
Wiggert A. van Cappellen
AHAdriaan B. Houtsmuller
Adriaan B. Houtsmuller
WVWim Vermeulen
Wim Vermeulen
The DNA polymerase processivity factor proliferating cell nuclear antigen (PCNA) is central to both DNA replication and repair. The ring-shaped homotrimeric PCNA encircles and slides along double-stranded DNA, acting as a “sliding clamp” that localizes proteins to DNA. We determined the behavior of green fluorescent protein-tagged human PCNA (GFP-hPCNA) in living cells to analyze its different engagements in DNA replication and repair. Photobleaching and tracking of replication foci revealed a dynamic equilibrium between two kinetic pools of PCNA, i.e., bound to replication foci and as a free mobile fraction. To simultaneously monitor PCNA action in DNA replication and repair, we locally inflicted UV-induced DNA damage. A surprisingly longer residence time of PCNA at damaged areas than at replication foci was observed. Using DNA repair mutants, we showed that the initial recruitment of PCNA to damaged sites was dependent on nucleotide excision repair. Local accumulation of PCNA at damaged regions was observed during all cell cycle stages but temporarily disappeared during early S phase. The reappearance of PCNA accumulation in discrete foci at later stages of S phase likely reflects engagements of PCNA in distinct genome maintenance processes dealing with stalled replication forks, such as translesion synthesis (TLS). Using a ubiquitination mutant of GFP-hPCNA that is unable to participate in TLS, we noticed a significantly shorter residence time in damaged areas. Our results show that changes in the position of PCNA result from de novo assembly of freely mobile replication factors in the nucleoplasmic pool and indicate different binding affinities for PCNA in DNA replication and repair.

4 April 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CBCéline BALDEYRON
Céline BALDEYRON
GSGaston Soria
Gaston Soria
DRDanièle Roche
Danièle Roche
ACAdam J. L. Cook
Adam J. L. Cook
GAGenevieve Almouzni
Genevieve Almouzni
Heterochromatin protein 1 (HP1), a major component of constitutive heterochromatin, is recruited to DNA damage sites. However, the mechanism involved in this recruitment and its functional importance during DNA repair remain major unresolved issues. Here, by characterizing HP1α dynamics at laser-induced damage sites in mammalian cells, we show that the de novo accumulation of HP1α occurs within both euchromatin and heterochromatin as a rapid and transient event after DNA damage. This recruitment is strictly dependent on p150CAF-1, the largest subunit of chromatin assembly factor 1 (CAF-1), and its ability to interact with HP1α. We find that HP1α depletion severely compromises the recruitment of the DNA damage response (DDR) proteins 53BP1 and RAD51. Moreover, HP1α depletion leads to defects in homologous recombination–mediated repair and reduces cell survival after DNA damage. Collectively, our data reveal that HP1α recruitment at early stages of the DDR involves p150CAF-1 and is critical for proper DNA damage signaling and repair.

20 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VMVirginie Maire
Virginie Maire
CBCéline BALDEYRON
Céline BALDEYRON
MRMarion Richardson
Marion Richardson
BTBruno Tesson
Bruno Tesson
AVAnne Vincent-Salomon
Anne Vincent-Salomon
TDThierry Dubois
Thierry Dubois
Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death. A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level. The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues. We confirmed by immunohistochemistry and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups. We then determined the biological effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines. We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner. Moreover, we observed that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy. Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis. These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis associated subgroup of breast cancer.

1 November 2007 in Molecular Cell
Verified
Journal Article
Closed access
MMMauro Modesti
Mauro Modesti
MBMagda Budzowska
Magda Budzowska
CBCéline BALDEYRON
Céline BALDEYRON
Jeroen A. A. DemmersJeroen A. A. Demmers
Jeroen A. A. Demmers
RGRodolfo Ghirlando
Rodolfo Ghirlando
RKRoland Kanaar
Roland Kanaar

21 February 2002 in Oncogene
Verified
Journal Article
Closed access
PDF file
CBCéline BALDEYRON
Céline BALDEYRON
EJEmilie Jacquemin
Emilie Jacquemin
JSJulianne Smith
Julianne Smith
CJCéline Jacquemont
Céline Jacquemont
IOIsabelle De Oliveira
Isabelle De Oliveira
DPDora Papadopoulo
Dora Papadopoulo

1 January 2006 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
FRFlavie Robert
Flavie Robert
SHSara Hardy
Sara Hardy
ZNZita Nagy
Zita Nagy
CBCéline BALDEYRON
Céline BALDEYRON
RMRabih Murr
Rabih Murr
Laszlo ToraLaszlo Tora
Laszlo Tora
Transactivation-transformation domain-associated protein (TRRAP) is a component of several multiprotein histone acetyltransferase (HAT) complexes implicated in transcriptional regulation. TRRAP was shown to be required for the mitotic checkpoint and normal cell cycle progression. MRE11, RAD50, and NBS1 (product of the Nijmegan breakage syndrome gene) form the MRN complex that is involved in the detection, signaling, and repair of DNA double-strand breaks (DSBs). By using double immunopurification, mass spectrometry, and gel filtration, we describe the stable association of TRRAP with the MRN complex. The TRRAP-MRN complex is not associated with any detectable HAT activity, while the isolated other TRRAP complexes, containing either GCN5 or TIP60, are. TRRAP-depleted extracts show a reduced nonhomologous DNA end-joining activity in vitro. Importantly, small interfering RNA knockdown of TRRAP in HeLa cells or TRRAP knockout in mouse embryonic stem cells inhibit the DSB end-joining efficiency and the precise nonhomologous end-joining process, further suggesting a functional involvement of TRRAP in the DSB repair processes. Thus, TRRAP may function as a molecular link between DSB signaling, repair, and chromatin remodeling.